IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Willie Hsung who wrote (477)	3/15/1997 4:24:00 PM
From: I. Luttichuys	of 1762

Yes. I am studying for finals so I can't go into all the reasons why I would (and did!) but, here are a few... Current EPS estimates support continuing appreciation in this stock's value... (12 month targets of $43 and $52) There is a psychological factor related to the fact this will be the first monoclonal approved in the US for the treatment of CA. Do you remember the hype over monoclonals in the 80s? There are many pharmaceutical companies out there far more removed from earnings which are selling for more. We are not even at a 52 week high and things are much improved since that high... great clinicals and even an acquired drug which before was not even in the pipeline. Zach's rates IDEC at no. 2 out of 110 biotechs with respect to analyst's ratings. I expect Merill Lynch to issue a strong buy on IDPH which should further bolster this standing. IDEC seems quite good at handling the business side of the house. Earnings show them to be quite able to work responsibly with what resources they have. A BLA has been filled. Many pharmaceuticals rise under this circumstance as the potential approval approaches. The FDA is familiar with C2B8 already as they appear to be using this therapy to help set the very criteria for "fast-track" CA drug handling under which it will probably be approved. There are other reasons as well. I understand the hesitancy in buying a stock after such a run up but, I certainly don't think this is the end of IDEC! I have owned this stock since the single digits. What reason do I have not to believe it will head above 28? It's not like that's even new territory as I've pointed out. If IDEC flattens out at, or near, this level, I will consider that a "buy" signal and will buy more. BENNETT PS: I have put a friend in IDPH as well at this price. It may fall and it may not but being long, its the future of this company I am focused on and not the day to day price fluctuations although, with this stock, as well as many others, they can certainly be annoying :o).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next